Chronic lymphocytic leukaemia and Rheumatoid arthritis

The association between chronic lymphocytic leukaemia and rheumatoid arthritis has been confirmed in some cases. Rheumatoid arthritis is a chronic autoimmune inflammatory disease characterized by erosive arthritis of the joints.
Chronic lymphocytic leukaemia is a clonal malignancy of lymphocytes, which is manifested by immunosuppression, bone marrow failure, and organ infiltration with neoplastic cells.

Showing all 7 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Rituximab H0209B04	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	2018.09	145,00 €	view product Max: 10 Min: 2 Step: 1
Rituximab N7129B16	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	2018.12	145,00 €	view product Max: 10 Min: 2 Step: 1
Rituximab N7135B11	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	2019.02	145,00 €	view product Max: 10 Min: 2 Step: 1
Rituximab N7135B18	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	2019.02	145,00 €	view product Max: 10 Min: 2 Step: 1
Rituximab N7174B06	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	2019.08	145,00 €	view product Max: 10 Min: 2 Step: 1
Rituximab N7190B08	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	2019.12	145,00 €	view product Max: 10 Min: 2 Step: 1
Rituximab N7321B38	CD20	Monoclonal Antibody	MabThera®	10 mg/mL	–	2 mg	-80°C	2021.07	145,00 €	view product Max: 10 Min: 2 Step: 1